tiprankstipranks
pc:cryst

Crystalys Therapeutics

San Diego, California 92130, US
https://crystalystx.com/
Crystalys Therapeutics is a biopharmaceutical company dedicated to advancing global Phase 3 clinical studies of dotinurad, a next-generation URAT1 inhibitor for the treatment of gout. The company leverages a world-class team with extensive experience in gout drug development and regulatory success, aiming to deliver a treatment with potential best-in-class safety and efficacy. Dotinurad has already demonstrated robust efficacy and a well-defined safety profile in multiple clinical studies across Asia, leading to its approval in Japan, China, Philippines, and Thailand.

Leadership & Board

Current Number of Employees16
Current LinkedIn Followers2,040

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$205M
Total Amount Raised$205M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$205M
Latest Funding Amount$205M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Company Momentum Positive

Articles Published on TipRanks3
Articles Published on TipRanks
3
LinkedIn Trend+0.20% followers
LinkedIn Trend
+0.20% followers
Workforce Trend+6.7% employees
Workforce Trend
+6.7% employees
Crystalys Therapeutics LinkedIn following is increasing, signaling rising market interest, but its workforce is shrinking indicating potential contraction.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.

Employee Trend

Crystalys Therapeutics had 16 employees as of April 6, 2026. The number of employees increased by 1 (6.67%) week-over-week.
16Latest Employee Count
1(6.67%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Crystalys Therapeutics had 2,040 followers as of April 6, 2026. The number of followers increased by 4 (0.20%) week-over-week.
2,040Latest Followers Count
4(0.20%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Series A
$205.00M

Investors

Investor Name
Funding Round

Related News and Analysis